These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prevalence and mechanisms of aminoglycoside resistance. A ten-year study. Phillips I, King A, Shannon K. Am J Med; 1986 Jun 30; 80(6B):48-55. PubMed ID: 3728534 [Abstract] [Full Text] [Related]
3. [The role of aminoglycoside--modifying enzymes in resistance of Gram-negative rods]. Jakoniuk P, Wieczorek P, Sacha PT, Zalewska M, Leszczyńska K. Med Dosw Mikrobiol; 2006 Jun 30; 58(4):363-70. PubMed ID: 17642314 [Abstract] [Full Text] [Related]
8. Comparison of the in vitro activities of BB-K8 and three other aminoglycosides against 215 strains of Pseudomonas and Enterobacteriaceae with variable sensitivity to kanamycin and gentamicin. Yourassowsky E, Schoutens E, Vanderlinden MP. Chemotherapy; 1975 Oct 30; 21(1):45-51. PubMed ID: 807457 [Abstract] [Full Text] [Related]
10. [Fluoroquinolone and aminoglycoside resistance in chromosomal cephalosporinase-overproducing gram-negative bacilli strains with inducible beta-lactamase]. López-Yeste M, Xercavins M, Lite J, Cuchí E, Garau J. Enferm Infecc Microbiol Clin; 1996 Apr 30; 14(4):211-4. PubMed ID: 9044634 [Abstract] [Full Text] [Related]
11. Molecular epidemiology of two genes encoding 3-N-aminoglycoside acetyltransferases AAC(3)I and AAC(3)II among gram-negative bacteria from a Spanish hospital. Alvarez M, Mendoza MC. Eur J Epidemiol; 1993 Nov 30; 9(6):650-7. PubMed ID: 8150069 [Abstract] [Full Text] [Related]
13. [Comparative activity of habekacin and 4 other aminoglycosides against gram-negative bacilli. Evolution of resistance]. Reynaud AE, Coude du Foresto B, Derriennic M, Courtieu AL. Pathol Biol (Paris); 1988 May 30; 36(5):435-8. PubMed ID: 3136424 [Abstract] [Full Text] [Related]
15. In vitro activity of isepamicin and other aminoglycosides against clinical isolates of Gram-negative bacteria causing nosocomial bloodstream infections. Tsai TY, Chang SC, Hsueh PR, Feng NH, Wang JT. J Microbiol Immunol Infect; 2007 Dec 30; 40(6):481-6. PubMed ID: 18087627 [Abstract] [Full Text] [Related]
16. Aminoglycoside resistance patterns in clinical isolates of Enterobacteriaceae from Czechoslovakia. Kettner M, Navarová J, Langsádl L. J Antimicrob Chemother; 1987 Sep 30; 20(3):383-7. PubMed ID: 3680076 [Abstract] [Full Text] [Related]
17. Amikacin-resistant gram-negative bacilli: correlation of occurrence with amikacin use. Levine JF, Maslow MJ, Leibowitz RE, Pollock AA, Hanna BA, Schaefler S, Simberkoff MS, Rahal JJ. J Infect Dis; 1985 Feb 30; 151(2):295-300. PubMed ID: 3918124 [Abstract] [Full Text] [Related]
18. Prevalence of extended spectrum beta-lactamase among multidrug resistant gram-negative isolates from a general hospital in Saudi Arabia. Kader AA, Kumar AK. Saudi Med J; 2004 May 30; 25(5):570-4. PubMed ID: 15138522 [Abstract] [Full Text] [Related]
19. Aminoglycoside resistance mechanisms in Enterobacteriaceae and Pseudomonas spp. from two Danish hospitals: correlation with type of aminoglycoside used. Busch-Sørensen C, Sönmezoglu M, Frimodt-Møller N, Højbjerg T, Miller GH, Espersen F. APMIS; 1996 Oct 30; 104(10):763-8. PubMed ID: 8980628 [Abstract] [Full Text] [Related]
20. [Continuous surveillance of antimicrobial resistance among nosocomial gram-negative bacilli from intensive care units in China]. Chen MJ, Wang H, China Nosocomial Pathogens Resistance Surveillance Study Group. Zhonghua Yi Xue Za Zhi; 2003 Mar 10; 83(5):375-81. PubMed ID: 12820912 [Abstract] [Full Text] [Related] Page: [Next] [New Search]